Viewing Study NCT00412347



Ignite Creation Date: 2024-05-05 @ 5:13 PM
Last Modification Date: 2024-10-26 @ 9:29 AM
Study NCT ID: NCT00412347
Status: COMPLETED
Last Update Posted: 2014-02-11
First Post: 2006-12-14

Brief Title: Insulin Infusion in the Hospital Wards
Sponsor: Emory University
Organization: Emory University

Study Overview

Official Title: Insulin Infusion and Outcomes for Non-Critical Wards
Status: COMPLETED
Status Verified Date: 2014-02
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: Increasing evidence from clinical studies in Intensive Care Unit ICU settings indicates that insulin infusion can improve outcome measures for patients with hyperglycemia high blood sugar independent of a previous diagnosis of diabetes mellitus This improvement in health could also apply to patients that have high blood sugars in various other non-critical care areas of the hospital as well However the data that shows improvement in health outcomes has been collected from wards that have a lower patient to provider and patient to nurse ratio resulting in the ability for a much tighter control of the insulin infusion We hypothesize that tight blood glucose control will provide the same benefits for patients in non-intensive care units settings but that these protocols may lead to a higher incidence of hypoglycemia low blood sugar and potentially to adverse outcomes in patients

This study aims to determine the clinical outcome of patients treated with insulin infusion as well as the rate of hypoglycemic episodes in non-intensive areas We will conduct a chart review of patients treated with insulin infusions in non-critical wards at Emory University Hospital during the period of 7104 to 63005 Medical records of all patients treated with intravenous insulin infusion protocols will be analyzed Data on demographics laboratory values mortality rate rate of hypoglycemic events length of stay as well as disposition at discharge will be analyzed
Detailed Description: None

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None
Secondary IDs
Secondary ID Type Domain Link
1203-2005 OTHER Other None